In the second paragraph of “Acknowledgments” on page 2407, funding from the Chapman and Perelman Foundation was not mentioned. The error has been corrected in the published article.
© 2019 by The American Society of Hematology
2019
Skip Nav Destination
ERRATUM|
September 12, 2019
Manasanch EE, Han G, Mathur R, et al. A pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune, and genomic analysis. Blood Adv. 2019;3(15):2400-2408.
Blood Adv (2019) 3 (18): 2712.
Article history
Submitted:
August 22, 2019
Accepted:
August 22, 2019
